यह एपिसोड यूके MHRA के राष्ट्रीय रोगी सुरक्षा अलर्ट (NatPSA/2026/005/MHRA) पर केंद्रित है, जो रोगी होइस्ट (patient hoists) और स्लिंग (slings) से संबंधित है। हम MHRA द्वारा पहचानी गई गिरने से होने वाली मौतों और गंभीर चोटों के विशिष्ट जोखिमों पर चर्चा करते हैं, जिनमें यांत्रिक विफलताएं और उपयोगकर्ता त्रुटियां शामिल हैं। हम स्वास्थ्य सेवा प्रदाताओं और निर्माताओं के लिए 29 सितंबर, 2026 की समय सीमा तक इन जोखिमों को कम करने के लिए आवश्यक कार्रवाइयों का विवरण देते हैं। Key Questions: - यूके MHRA की रोगी

Cơ quan Quản lý Thuốc và Sản phẩm Chăm sóc Sức khỏe của Vương quốc Anh (MHRA) đã ban hành Cảnh báo An toàn Bệnh nhân Quốc gia (NatPSA/2026/005/MHRA) quan trọng, giải quyết các rủi ro tử vong và thương tích nghiêm trọng do ngã từ thiết bị nâng bệnh nhân và dây treo. Tập này phân tích các hành động bắt buộc đối với các nhà cung cấp dịch vụ chăm sóc sức khỏe và nhà sản xuất thiết bị y tế, bao gồm các yêu cầu cập nhật tài liệu, tăng cường đào tạo và cải thiện các quy trình an toàn. Chúng tôi thảo luận

В этом выпуске мы подробно рассматриваем Национальное предупреждение о безопасности пациентов (NatPSA/2026/005/MHRA), выпущенное Управлением по регулированию лекарственных средств и изделий медицинского назначения Великобритании (MHRA). Мы обсуждаем серьезные риски падений, связанные с подъемниками для пациентов и стропами, включая механические неисправности и ошибки пользователей. Эпизод освещает обязательные действия, которые производители и поставщики медицинских услуг должны предпринять до 29

Episode ini membahas secara mendalam Peringatan Keselamatan Pasien Nasional (NatPSA/2026/005/MHRA) dari MHRA Inggris mengenai risiko serius yang terkait dengan alat pengangkat pasien (patient hoists) dan gendongan (slings). Kami menguraikan tindakan yang diperlukan bagi produsen dan penyedia layanan kesehatan untuk mengurangi risiko jatuh yang fatal sebelum batas waktu 29 September 2026. Pelajari langkah-langkah praktis yang harus diambil oleh tim regulasi dan kualitas Anda, termasuk meninjau

Kan ve gül, gülle diken, aşkım ve sen

Delayed Friday edition, recorded October 2. Lilly's Jaypirca (pirtobrutinib) gains first-line approval for adults with CLL/SLL without a known 17p deletion—but how does a trial against older chemotherapy guide today's treatment choice? Novartis agrees to $575 million upfront for Abogen's early-stage RNA medicine ABO2203, with closing still pending and autoimmune benefit unproven. Also: Pfizer's Litfulo (ritlecitinib) advances toward vitiligo filings; Biogen reports longer-term

Get in touch to share sheeping stories or questions anytime! We love hearing from our listeners and in this episode we answer some interesting questions from listeners on routine hoof care for sheep and how and when to castrate lambs. Andrew recently attended the Irish Lanark society sale in Roscommon and his buying strategy paid off big time! Thanks for listening! Thank you for supporting our pod! Sign up via our sheep supporters tab ! https://www.buzzsprout.com/954910/supporter...

Ти можеш змінити віру, партію чи ставлення до війни. А чи можеш зробити так, щоб партнер дізнався про це останнім?Дві позиції, жодної згоди. Перша: мовчання і є порушенням договору, якого ніхто не озвучував. Друга: мовчання буває межею, а не порушенням довіри.Чесно про докази: жодне з використаних досліджень не міряє зміну світогляду всередині шлюбу. Ми спираємось на найближче: як релігійні й політичні розбіжності між подружжям та приховування в парах пов'язані зі стабільністю й якістю

This digest covers key developments from Shionogi, Alector and Eli Lilly, including corporate acquisitions, a Parkinson’s disease licensing deal and a first-line label expansion, alongside broader coverage across the sector.This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

In this classic episode of Stuff to Blow Your Mind, Robert and Joe discuss the idea of Egyptian tomb curses, how they actually factored into ancient Egyptian practices and where the myth of the Pharaoh's curse meets reality. (originally published 9/30/2025)See omnystudio.com/listener for privacy information.

Un logiciel qui repère le stade B2 de la maladie valvulaire mitrale sans échographe, une sonde thermique censée trier lipomes et mastocytomes, des assistants grand public qui notent des radios de veaux face à de jeunes vétérinaires : Mathieu Lamant et Julie passent ces promesses au crible, chiffres et limites compris. Ils s'arrêtent ensuite sur la flagornerie numérique, cette tendance des IA à valider l'hypothèse de leur utilisateur, puis sur deux évolutions de VetInterniste qui confrontent l'image

In questo episodio, analizziamo l'avviso di sicurezza dei dispositivi (DSI/2026/012) emesso dalla MHRA del Regno Unito il 29 settembre 2026, riguardante i sistemi di cardiotocografia (CTG) wireless. Approfondiamo i rischi specifici di crossover del segnale e di interruzione del segnale identificati dalla MHRA e discutiamo le implicazioni critiche per la conformità post-commercializzazione e la gestione del rischio per i produttori di dispositivi medici abilitati alla radiofrequenza.Key

Planetterrian Daily 🌍 Planetterrian Daily - Science, Longevity & Health Discoveries A single mitochondrial protein links the circadian clock directly to brown fat metabolism in new Science findings. Top 15 Science & Health Discoveries Skin functions as dynamic organ beyond appearance — Yahoo Creators Skin performs immune surveillance, temperature regulation, vitamin D synthesis, and microbiome support. ... Sources: creators.yahoo.com · bioengineer.org · science.org · nytimes.com ·

Business Creativity and Innovation in Pharma 4.0What happens when one of the world’s most highly regulated industries embraces creativity, experimentation, artificial intelligence, and digital technologies? In this episode of Center of Excellence - Pharma 4.0, we explore how business creativity and innovation can reshape the pharmaceutical industry—not by compromising scientific rigor or regulatory compliance, but by creating smarter, safer, faster, and more adaptive ways of working. The discussion

In his weekly clinical update, Daniel Griffin and Vincent Racaniello continue their ongoing exasperation over 5 deaths in Pennsylvania associated with measles infections, the absurdity of RFK Jr.'s statement that AI is better informed than physicians, the outbreak of cholera, more deaths by raw milk products, spread of dengue virus in Florida, Ebola in DRC, refusal to acknowledge the benefits of the HBV vaccine birth dose, how TORCH agent infections impact neurodevelopment and may lead to increase

👉 Quer receber os áudios todos os dias no seu WhatsApp? https://vedanta.com.br/podcast 🎓 Cursos Gratuitos e Turmas Regulares: https://vedanta.com.br/

Mensagem por Manoel Geraldo, Instagram [@_manoelgeraldo] no OFAROL Igreja [@ofaroligreja] em Olinda/PE. Siga-nos!

Normalmente venimos a hablar de avances. Hoy toca lo contrario: tres grandes fases 3 en cardiovascular, de AstraZeneca, Novartis y Novo Nordisk, con miles de pacientes cada uno. Los tres han fallado, y nos centramos en dos. Novartis atacaba la lipoproteína(a), el "colesterol genético": un factor de riesgo muy validado para el que no existe tratamiento. Novo Nordisk apostaba por la hipótesis de la inflamación con un anti-IL-6 que llegó con la compra de Corvidia, la compañía de Marc de Garidel

Rob Dodge says AI has made him an expert Python programmer, even though he never took a class in it. But does having new capabilities change what it means to be a scientist?Dr. Chad Briscoe sits down with Dr. Robert “Rob” Dodge at the AAPS National Biotechnology Conference in San Diego to discuss how artificial intelligence and machine learning are changing pharmaceutical research.Thank you to our sponsorsTruTechnologies provides real-time clinical trial oversight, helping research teams improve

If the sun didn't power the photosynthesis of green plants, we wouldn't be breathing right now. And without the finely tuned properties of water, Earth would be a frozen, lifeless wasteland. Coincidence? Or is something else at work? On this classic episode of ID The Future out of the archive, host Andrew McDiarmid continues his ongoing series with Dr. Jonathan McLatchie unpacking the many features of our planet and the cosmos that allow for advanced life like ours to exist. Here, the discussion